.
Feedback

Photos: Two Celebrate Supervisor Victory, Others Thank Supporters

Warren Slocum and Shelly Masur will face a run-off in November.

Though there can only be one winner for the District 4 Supervisor seat in November, two have advanced to the run-off. Former Chief Elections Officer & County Assessor-Clerk Recorder Warren Slocum gained nearly 40 percent of the vote and school board member Shelly Masur nabbed around 21 percent of the vote in the county-wide election.

Slocum celebrated at Nimbus Design on 2363 Broadway, while Masur held a party with the San Mateo County Labor Council in San Mateo.

Menlo Park Mayor Kirsten Keith--with almost 15 percent-- and Menlo Park city councilmember Andy Cohen--with 5 percent--went on with business as usual upon the Menlo Park dais.

Candidate Memo Morantes gained almost 8 percent of the vote and thanked supporters at a party at the in Redwood City.

Planning Commissioner Vice Chair Ernie Schmidt totaled 3 percent of the vote and had a gathering at his home, while East Palo Alto Councilman Carlos Romero tallied almost 9 percent of the vote.

 

Follow us on Twitter | Like us on Facebook | | Blog for us

Newsletter & Alerts

Get the best stories each day and important breaking news

Subscribe

Not from Pacifica Patch? Find your Local Patch »

Loading comments ...
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors. Write a new post... What's up? Make an announcement, speak your mind, or sell something
Hnin May 24, 2013 at 06:31 pm
Please help share it on your facebook as well. Anything to find our cat.Read More http://sfbay.craigslist.org/pen/laf/3825190526.html
Janet Arline Barker May 17, 2013 at 11:18 am
Awesome! Next Tuesday, Thursday or Friday are open. Name a time and place. I used to write 3Read More different columns for San Bruno, Millbrae, and Burlingame Patch. I am ready to write for Pacifica Patch & blog too. Here's my personal blog...I do sporadically. Www.art-Janet.blogspot.com My art studio is at Sanchez Art Center #11
Christa Bigue (Editor) May 17, 2013 at 11:05 am
When can we meet for coffee Janet? Since you're the first one to post in our biz update section youRead More get to have coffee and chat with your local Patch editor! Email me at christa.bigue@patch.com and we'll find a date and place.
Anon. April 14, 2013 at 01:43 am
I can start with the comments on the Theravance drug, fluticasone fluroate - the active moiety inRead More this compound is the same, fluticasone (proprionate) that has been marketed by GSK for the same indication for approximately 25 years. Indeed, that patent is so old, and the drug has such a proven track record for safety and efficacy, that the patent has expired and there are generic versions available. There is also in implicit assumption by the author that the only reason that the FDA will approve medications in a short time span is because they are for 'life-or-limb' or unmet serious medical need. This is just not the case - regulators in many countries, including the FDA in the USA, may give accelerated approval to a product, where the safety and tolerability of a product is equivalent to a similar active agent which has already been approved. I suspect this is the case for fluticasone fluroate - but I am not privy to the details of the regulatory filing. I note that none of the companies mentioned here, nor the FDA, has provided input to this article. The journalism in this article smacks of someone trying to make a name for themselves quickly by scaring uneducated and/or anxious people. The science is just plain flawed.
Pacificat April 12, 2013 at 12:49 pm
Please tell us in what ways it is ill-informed
Anon. April 11, 2013 at 08:22 pm
Ill-informed, sensationalist rubbish.
Deb Wong March 26, 2013 at 06:09 pm
Thanks, Stacie!
Stacie Chan (Editor) March 26, 2013 at 02:51 pm
Absolutely stunning photos, Deb! Thanks for sharing. I really feel like I was there by just perusingRead More your photo gallery.